Evaluation of cytotoxicity of six different flowable composites with the methyl tetrazolium test method

Abstract

Abstract Background: The aim of this study was to investigate the cytotoxicity of six different flowable composites with the methyl tetrazolium test (MTT). Materials and Methods: For MTT, six different flowable composites (Bisco Aelite, Bisco Inc., USA; Esthet X Flow, Dentsply, USA; Filtek™ Supreme XT Flowable Restorative, 3M Espe, USA; Gradia ® Direct Flo, GC, USA; Estelite ® Flow Quick, Tokuyama Dental Corporation, Japan; and Clearfil Majesty Flow, Kuraray Medical Inc., Japan) were prepared according to the manufacturer’s instructions in standard Teflon disks (2 mm × 5 mm) and the samples were extracted in 7 ml of Basal Medium Eagle with 10% new born calf serum and 5% penicillin streptomycin gentamisin for 24 h. In the experiments: The L929 cells were plated (25.000 cells/ml) in wells of 96 well-dishes and maintained in a humidified incubator for 24 h at 37°C, 5% CO2, and 95% of air. After 24 h incubation of the cells, the incubation medium was replaced by the immersed medium in which the samples were stored. Then L929 cells were incubated in contact with evaluates for 24 h. The cell mitochondrial activity was evaluated by the MTT. 12 well used for each specimen and MTT tests applied 2 times. The data were submitted to the statistically analyzed by one-way ANOVA and Tukey’s honestly significant difference (HSD) tests. Results: According to the results of MTT test with L-929 fibroblasts demonstrated that all freshly prepared flowable composites did not reduce vital cell numbers (P>0.05) in comparison to control group. Conclusion: This study revealed important information for clinical applications of flowable composites in dentistry.